Literature DB >> 20016963

Structural changes associated with progression of motor deficits in spinocerebellar ataxia 17.

Kathrin Reetz1, Rebekka Lencer, Johannes M Hagenah, Christian Gaser, Vera Tadic, Uwe Walter, Alexander Wolters, Susanne Steinlechner, Christine Zühlke, Katja Brockmann, Christine Klein, Arndt Rolfs, Ferdinand Binkofski.   

Abstract

Spinocerebellar ataxia (SCA17) is a rare genetic disorder characterized by a variety of neuropsychiatric symptoms. Recently, using magnetic resonance imaging (MRI) voxel-based morphometry (VBM), several specific functional-structural correlations comprising differential degeneration related to motor and psychiatric symptoms were reported in patients with SCA17. To investigate gray matter volume (GMV) changes over time and its association to clinical neuropsychiatric symptomatology, nine SCA17 mutation carriers and nine matched healthy individuals underwent a detailed neuropsychiatric clinical examination and a high-resolution T1-weighted volume MRI scan, both at baseline and follow-up after 18 months. Follow-up images revealed a progressive GMV reduction in specific degeneration patterns. In contrast to healthy controls, SCA17 patients showed a greater atrophy not only in cerebellar regions but also in cortical structures such as the limbic system (parahippocampus, cingulate) and parietal precuneus. Clinically, progression of motor symptoms was more pronounced than that of psychiatric symptoms. Correlation with the clinical motor scores revealed a progressive reduction of GMV in cerebellar and cerebral motor networks, whereas correlation with psychiatric scores displayed a more widespread GMV impairment in frontal, limbic, parietal, and also cerebellar structures. Interestingly, changes in global functioning were correlated with bilateral atrophy within the para-/hippocampus. While there was a good temporal association between worsening of motor symptoms and progression in cerebral and cortical neurodegeneration, the progression in psychiatric related neurodegeneration seemed to be more widespread and complex, showing progressive atrophy that preceded the further development of clinical psychiatric symptoms.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20016963     DOI: 10.1007/s12311-009-0150-4

Source DB:  PubMed          Journal:  Cerebellum        ISSN: 1473-4222            Impact factor:   3.847


  36 in total

1.  An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets.

Authors:  Joseph A Maldjian; Paul J Laurienti; Robert A Kraft; Jonathan H Burdette
Journal:  Neuroimage       Date:  2003-07       Impact factor: 6.556

Review 2.  Basal ganglia-thalamocortical circuits: parallel substrates for motor, oculomotor, "prefrontal" and "limbic" functions.

Authors:  G E Alexander; M D Crutcher; M R DeLong
Journal:  Prog Brain Res       Date:  1990       Impact factor: 2.453

3.  Dopamine transporter positron emission tomography in spinocerebellar ataxias type 1, 2, 3, and 6.

Authors:  Ullrich Wüllner; Michael Reimold; Michael Abele; Katrin Bürk; Martina Minnerop; Bernd-Michael Dohmen; Hans-Juergen Machulla; Roland Bares; Thomas Klockgether
Journal:  Arch Neurol       Date:  2005-08

4.  Cerebellar cognitive affective syndrome.

Authors:  J D Schmahmann; J C Sherman
Journal:  Int Rev Neurobiol       Date:  1997       Impact factor: 3.230

5.  A voxel-based morphometric study of ageing in 465 normal adult human brains.

Authors:  C D Good; I S Johnsrude; J Ashburner; R N Henson; K J Friston; R S Frackowiak
Journal:  Neuroimage       Date:  2001-07       Impact factor: 6.556

6.  Reduced hippocampal volume correlates with executive dysfunctioning in major depression.

Authors:  Thomas Frodl; Annette Schaub; Sandra Banac; Marketa Charypar; Markus Jäger; Petra Kümmler; Ronald Bottlender; Thomas Zetzsche; Christine Born; Gerda Leinsinger; Maximilian Reiser; Hans-Jürgen Möller; Eva M Meisenzahl
Journal:  J Psychiatry Neurosci       Date:  2006-09       Impact factor: 6.186

7.  Differential limbic--cortical correlates of sadness and anxiety in healthy subjects: implications for affective disorders.

Authors:  M Liotti; H S Mayberg; S K Brannan; S McGinnis; P Jerabek; P T Fox
Journal:  Biol Psychiatry       Date:  2000-07-01       Impact factor: 13.382

8.  Predominant dystonia with marked cerebellar atrophy: a rare phenotype in familial dystonia.

Authors:  J Hagenah; K Reetz; C Zühlke; A Rolfs; F Binkofski; C Klein
Journal:  Neurology       Date:  2007-06-12       Impact factor: 9.910

9.  Limbic and frontal cortical degeneration is associated with psychiatric symptoms in PINK1 mutation carriers.

Authors:  Kathrin Reetz; Rebekka Lencer; Susanne Steinlechner; Christian Gaser; Johann Hagenah; Christian Büchel; Dirk Petersen; Norman Kock; Ana Djarmati; Hartwig R Siebner; Christine Klein; Ferdinand Binkofski
Journal:  Biol Psychiatry       Date:  2008-02-07       Impact factor: 13.382

10.  Spinocerebellar ataxia type 17: report of a family with reduced penetrance of an unstable Gln49 TBP allele, haplotype analysis supporting a founder effect for unstable alleles and comparative analysis of SCA17 genotypes.

Authors:  Christine Zühlke; Andreas Dalski; Eberhard Schwinger; Ulrich Finckh
Journal:  BMC Med Genet       Date:  2005-07-01       Impact factor: 2.103

View more
  14 in total

1.  CAG repeats determine brain atrophy in spinocerebellar ataxia 17: a VBM study.

Authors:  Kathrin Reetz; Alexandra Kleiman; Christine Klein; Rebekka Lencer; Christine Zuehlke; Kathrin Brockmann; Arndt Rolfs; Ferdinand Binkofski
Journal:  PLoS One       Date:  2011-01-19       Impact factor: 3.240

2.  Consensus paper: radiological biomarkers of cerebellar diseases.

Authors:  Leonardo Baldarçara; Stuart Currie; M Hadjivassiliou; Nigel Hoggard; Allison Jack; Andrea P Jackowski; Mario Mascalchi; Cecilia Parazzini; Kathrin Reetz; Andrea Righini; Jörg B Schulz; Alessandra Vella; Sara Jane Webb; Christophe Habas
Journal:  Cerebellum       Date:  2015-04       Impact factor: 3.847

3.  Genetic variation in ataxia gene ATXN7 influences cerebellar grey matter volume in healthy adults.

Authors:  Charlotte D C C van der Heijden; Mark Rijpkema; Alejandro Arias-Vásquez; Marina Hakobjan; Hans Scheffer; Guillen Fernandez; Barbara Franke; Bart P van de Warrenburg
Journal:  Cerebellum       Date:  2013-06       Impact factor: 3.847

Review 4.  Magnetic resonance imaging biomarkers in patients with progressive ataxia: current status and future direction.

Authors:  Stuart Currie; Marios Hadjivassiliou; Ian J Craven; Iain D Wilkinson; Paul D Griffiths; Nigel Hoggard
Journal:  Cerebellum       Date:  2013-04       Impact factor: 3.847

5.  Quantitative analysis of upper-limb ataxia in patients with spinocerebellar degeneration.

Authors:  Naohisa Ueda; Yasuhito Hakii; Shigeru Koyano; Yuichi Higashiyama; Hideto Joki; Yasuhisa Baba; Yume Suzuki; Yoshiyuki Kuroiwa; Fumiaki Tanaka
Journal:  J Neurol       Date:  2014-04-30       Impact factor: 4.849

6.  Adult neurogenesis and neurite outgrowth are impaired in LRRK2 G2019S mice.

Authors:  B Winner; H L Melrose; C Zhao; K M Hinkle; M Yue; C Kent; A T Braithwaite; S Ogholikhan; R Aigner; J Winkler; M J Farrer; F H Gage
Journal:  Neurobiol Dis       Date:  2010-12-16       Impact factor: 5.996

7.  Investigating function and connectivity of morphometric findings--exemplified on cerebellar atrophy in spinocerebellar ataxia 17 (SCA17).

Authors:  Kathrin Reetz; Imis Dogan; Arndt Rolfs; Ferdinand Binkofski; Jörg B Schulz; Angela R Laird; Peter T Fox; Simon B Eickhoff
Journal:  Neuroimage       Date:  2012-05-30       Impact factor: 6.556

8.  Longitudinal Analysis of the Relation Between Clinical Impairment and Gray Matter Degeneration in Spinocerebellar Ataxia Type 7 Patients.

Authors:  Anabel Contreras; Gabriel Ramirez-Garcia; Amanda Chirino; Consuelo Morgado-Valle; Erick H Pasaye; Carlos Hernandez-Castillo; Rosalinda Díaz; Juan Fernandez-Ruiz; Luis Beltran-Parrazal
Journal:  Cerebellum       Date:  2020-11-12       Impact factor: 3.847

Review 9.  Rating scales and biomarkers for CAG-repeat spinocerebellar ataxias: Implications for therapy development.

Authors:  Meng-Ling Chen; Chih-Chun Lin; Liana S Rosenthal; Puneet Opal; Sheng-Han Kuo
Journal:  J Neurol Sci       Date:  2021-04-01       Impact factor: 3.181

10.  Severe and rapidly progressing cognitive phenotype in a SCA17-family with only marginally expanded CAG/CAA repeats in the TATA-box binding protein gene: a case report.

Authors:  Troels Tolstrup Nielsen; Skirmante Mardosiene; Annemette Løkkegaard; Jette Stokholm; Susanne Ehrenfels; Sara Bech; Lars Friberg; Jens Kellberg Nielsen; Jørgen E Nielsen
Journal:  BMC Neurol       Date:  2012-08-13       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.